Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 276.85%254.69K | -290.78%-222.71K | 109.42%46.13K | 46.99%-420.78K | 281.94%269.79K | 43.87%-144.02K | 77.02%-56.99K | -247.41%-489.57K | 36.75%-793.8K | 44.62%-148.28K |
| Net income from continuing operations | -2,017.28%-405.2K | -266.03%-70.27K | 46.86%-102.39K | 86.51%-168.79K | -55.15%21.95K | 104.44%21.13K | 95.98%-19.2K | 44.29%-192.68K | 60.51%-1.25M | 117.78%48.95K |
| Operating gains losses | 705.83%258.93K | 425.84%59.05K | -105.55%-4.22K | -72.08%-16.24K | -240.30%-31.42K | -2,247.69%-42.74K | -967.88%-18.12K | 15,400.40%76.04K | 96.50%-9.44K | -193.25%-9.23K |
| Depreciation and amortization | 2,769.98%65.78K | -3.80%2.3K | 0.00%2.44K | -25.43%9.42K | -6.18%2.29K | -19.58%2.29K | -34.72%2.39K | -33.50%2.44K | -38.60%12.63K | -50.38%2.44K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -99.24%15.54K | --0 |
| Remuneration paid in stock | -65.40%6.44K | -65.64%6.61K | -76.57%14.72K | 55.41%119.29K | 73.85%18.61K | 25.10%18.61K | 705.89%19.23K | 15.62%62.84K | -74.90%76.76K | -80.30%10.71K |
| Deferred tax | 119.08%1.21K | 123.09%2.28K | -78.25%1.35K | -117.94%-8.02K | 141.05%1.98K | -116.25%-6.35K | -567.46%-9.85K | -25.44%6.21K | 216.82%44.71K | -283.23%-4.82K |
| Other non cashItems | ---- | ---- | ---- | -133.58%-30.85K | --0 | ---16.13K | --0 | ---14.72K | -28.27%91.88K | --3.47K |
| Change In working capital | 371.07%327.53K | -608.22%-222.67K | 131.24%134.22K | -244.51%-325.59K | 228.32%256.38K | -175.01%-120.83K | -122.38%-31.44K | -447.78%-429.7K | 165.56%225.31K | -211.00%-199.8K |
| -Change in receivables | 655.44%229.65K | -163.67%-199.13K | 122.19%17.74K | 104.53%8.22K | 208.12%205.03K | -336.82%-41.35K | -310.16%-75.52K | -977.69%-79.94K | -422.20%-181.47K | -590.59%-189.62K |
| -Change in prepaid assets | 180.46%13.56K | -71.41%3.1K | -0.06%10.83K | -99.59%22 | 77.74%-4.79K | -237.11%-16.85K | 373.10%10.83K | -11.85%10.84K | -96.21%5.34K | 27.95%-21.53K |
| -Change in payables and accrued expense | 234.63%84.32K | -180.12%-26.64K | 129.30%105.66K | -183.16%-333.83K | 394.43%56.15K | -147.68%-62.63K | -78.77%33.25K | -452.98%-360.6K | 189.23%401.43K | 264.53%11.36K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 276.85%254.69K | -290.78%-222.71K | 109.42%46.13K | 46.99%-420.78K | 281.94%269.79K | 43.87%-144.02K | 77.02%-56.99K | -247.41%-489.57K | 36.75%-793.8K | 44.62%-148.28K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 15.07K | 0 | 0 | 0 | 0 | ||||
| Net PPE purchase and sale | --0 | ---- | ---- | --15.07K | --0 | --0 | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | --15.07K | --0 | --0 | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 75.78K | 5.98K | 0 | -106.21%-56.83K | -102.99%-27.39K | 0 | 0 | -29.44K | 76.75%915.58K | 915.58K |
| Net issuance payments of debt | --0 | --0 | --0 | ---29.44K | --0 | --0 | --0 | ---29.44K | --0 | --0 |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --915.58K | ---- |
| Proceeds from stock option exercised by employees | --75.78K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---27.39K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --75.78K | --5.98K | --0 | -106.21%-56.83K | -102.99%-27.39K | --0 | --0 | ---29.44K | 76.75%915.58K | 76.75%915.58K |
| Net cash flow | ||||||||||
| Beginning cash position | -16.13%375.36K | 20.96%592.09K | -45.86%545.96K | 13.73%1.01M | 25.85%303.56K | -10.09%447.58K | -34.37%489.5K | 13.73%1.01M | 367.67%886.73K | -61.83%241.21K |
| Current changes in cash | 327.89%330.47K | -429.59%-216.73K | 108.89%46.13K | -479.82%-462.55K | -68.41%242.4K | 43.48%-145.02K | 83.50%-40.92K | -268.30%-519.01K | -82.53%121.78K | 206.63%767.29K |
| End cash Position | 132.52%705.84K | -16.13%375.36K | 20.96%592.09K | -45.86%545.96K | -45.86%545.96K | 25.85%303.56K | -10.09%447.58K | -34.37%489.5K | 13.73%1.01M | 13.73%1.01M |
| Free cash from | 276.85%254.69K | -283.59%-222.71K | 109.42%46.13K | 46.86%-421.85K | 281.94%269.79K | 43.87%-144.02K | 76.59%-58.06K | -247.41%-489.57K | 36.75%-793.8K | 44.62%-148.28K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.